{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:07Z","timestamp":1791308827411,"version":"4.3.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.toxicon.2009.02.034","type":"journal-article","created":{"date-parts":[[2009,3,12]],"date-time":"2009-03-12T08:14:30Z","timestamp":1236845670000},"page":"600-613","source":"Crossref","is-referenced-by-count":11,"title":["Immune recognition of BoNTs A and B: How anti-toxin antibodies that bind to the heavy chain obstruct toxin action"],"prefix":"10.1016","volume":"54","author":[{"given":"M. Zouhair","family":"Atassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.toxicon.2009.02.034_bib1","doi-asserted-by":"crossref","first-page":"e3023","DOI":"10.1371\/journal.pone.0003023","article-title":"Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain","volume":"3","author":"Adekar","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.toxicon.2009.02.034_bib2","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/IAI.65.9.3743-3752.1997","article-title":"Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries","volume":"65","author":"Amersdorfer","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2009.02.034_bib3","series-title":"Scientific and Therapeutic Aspects of Botulinum Toxin","first-page":"103","article-title":"Immunologic and other properties of therapeutic botulinum toxin serotypes","author":"Aoki","year":"2002"},{"issue":"Suppl. 8","key":"10.1016\/j.toxicon.2009.02.034_bib81","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/mds.20020","article-title":"Basic immunological aspects of botulinum toxin therapy","volume":"19,","author":"Atassi","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2009.02.034_bib4","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1099\/mic.0.28862-0","article-title":"On the enhancement of anti-neurotoxin antibody production by subcomponents HA1 and HA3b of Clostridium botulinum type B 16S toxin-haemagglutinin","volume":"52","author":"Atassi","year":"2006","journal-title":"Microbiology"},{"issue":"Suppl. 8","key":"10.1016\/j.toxicon.2009.02.034_bib5","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/mds.20020","article-title":"Basic immunological aspects of botulinum toxin therapy","volume":"19","author":"Atassi","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2009.02.034_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1984.tb08516.x","article-title":"Antigenic structures of proteins. Their determination has revealed important aspects of immune recognition and generated strategies for synthetic mimicking or protein binding sites","volume":"145","author":"Atassi","year":"1984","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxicon.2009.02.034_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0019-2791(75)90010-5","article-title":"Antigenic structure of myoglobin. The complete immunochemical anatomy of a protein and conclusions relating to antigenic structures of proteins","volume":"12","author":"Atassi","year":"1975","journal-title":"Immunochemistry"},{"key":"10.1016\/j.toxicon.2009.02.034_bib8","series-title":"Botulinum Toxin: Therapeutic Clinical Practice & Science","first-page":"53","article-title":"Immune recognition of botulinum neurotoxin A and B: Molecular elucidation of immune protection against the toxins","author":"Atassi","year":"2009"},{"key":"10.1016\/j.toxicon.2009.02.034_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/B:JOPC.0000016257.91979.06","article-title":"Mapping of the antibody-binding regions on the HN-domain (residues 449\u2013859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A","volume":"23","author":"Atassi","year":"2004","journal-title":"Protein J."},{"key":"10.1016\/j.toxicon.2009.02.034_bib10","first-page":"927","article-title":"Antibody and T-cell recognition of \u03b1-bungarotoxin and its synthetic loop peptides","volume":"13","author":"Atassi","year":"1995","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib11","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.molimm.2005.01.016","article-title":"Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A","volume":"42","author":"Atassi","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib12","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.molimm.2008.06.031","article-title":"Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment","volume":"45","author":"Atassi","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/BF01886751","article-title":"Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855\u20131296 with anti-toxin antibodies from three host species","volume":"15","author":"Atassi","year":"1996","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.toxicon.2009.02.034_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1615\/CritRevImmunol.v27.i4.30","article-title":"Molecular bases of protective immune responses against botulinum neurotoxin A \u2013 how antitoxin antibodies block its action","volume":"27","author":"Atassi","year":"2007","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib15","first-page":"219","article-title":"Structure, activity and immune (T and B Cell) recognition of botulinum neurotoxin","volume":"19","author":"Atassi","year":"1999","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0161-5890(78)90016-0","article-title":"A proposal for the nomenclature of antigen sites in peptides and proteins","volume":"15","author":"Atassi","year":"1978","journal-title":"Immunochemistry"},{"key":"10.1016\/j.toxicon.2009.02.034_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/bj2460307","article-title":"Non-specific peptide size effects in the recognition by site-specific T-cell clones: demonstration with a T site of myoglobin","volume":"246","author":"Atassi","year":"1987","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2009.02.034_bib18","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/S0021-9258(18)61557-1","article-title":"Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis","volume":"262","author":"Bandyopadhyay","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2009.02.034_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1524-4725.2002.01116.x","article-title":"Botulinum toxin A: successful decollete rejuvenation","volume":"28","author":"Becker-Wegerich","year":"2002","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2009.02.034_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/mda.2002.24423","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine","volume":"48","author":"Binder","year":"2002","journal-title":"Dis. Mon."},{"key":"10.1016\/j.toxicon.2009.02.034_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1744-313X.1984.tb00820.x","article-title":"T cell recognition of myoglobin. Localization of the sites stimulating T cell proliferative responses by synthetic overlapping peptides encompassing the entire molecule","volume":"11","author":"Bixler","year":"1984","journal-title":"J. Immunogenet."},{"key":"10.1016\/j.toxicon.2009.02.034_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/bj2400139","article-title":"Site recognition by protein-primed T cells shows a non-specific peptide size requirement beyond the essential residues of the site. Demonstration by defining an immunodominant T site in myoglobin","volume":"240","author":"Bixler","year":"1986","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2009.02.034_bib23","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1517\/13543784.10.8.1531","article-title":"Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects","volume":"10","author":"Borodic","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.toxicon.2009.02.034_bib24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia","volume":"53","author":"Brashear","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2009.02.034_bib25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.toxicon.2009.02.034_bib26","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nature05411","article-title":"Structural basis of cell surface receptor recognition by botulinum neurotoxin B","volume":"444","author":"Chai","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2009.02.034_bib27","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2009.02.034_bib76","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/IAI.6.4.587-590.1972","article-title":"Role of a protease in natural activation of Clostridium botulinum neurotoxin","volume":"6","author":"Das Gupta","year":"1972","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2009.02.034_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4684-4331-8_6","article-title":"Genetic control and intersite influences on the immune response to sperm whale myoglobin","volume":"150","author":"David","year":"1982","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib29","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0264-410X(96)00094-1","article-title":"Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum","volume":"14","author":"Dertzbaugh","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.toxicon.2009.02.034_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1473-2165.2006.00250.x","article-title":"Botulinum toxin in dermatology \u2013 beyond wrinkles and sweat","volume":"5","author":"Diamond","year":"2006","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib77","first-page":"490","article-title":"\u03b1-Bungarotoxin peptides afford a synthetic vaccine against toxin poisoning","volume":"13","author":"Dolimbek","year":"1994","journal-title":"J. Prot. Chem."},{"key":"10.1016\/j.toxicon.2009.02.034_bib78","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0161-5890(96)00014-4","article-title":"Protection against alpha-bungarotoxin poisoning by immunization with synthetic toxin peptides","volume":"33","author":"Dolimbek","year":"1996","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib31","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.molimm.2006.03.011","article-title":"Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT\/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT\/A","volume":"44","author":"Dolimbek","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib32","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.molimm.2007.08.007","article-title":"Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin","volume":"45","author":"Dolimbek","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib33","first-page":"119","article-title":"Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449\u2013859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains","volume":"34","author":"Dolimbek","year":"2005","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.toxicon.2009.02.034_bib34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.toxicon.2009.02.034_bib35","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1021\/bi9723966","article-title":"Role of zinc in the structure and toxic activity of botulinum neurotoxin","volume":"37","author":"Fu","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2009.02.034_bib79","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nbt1269","article-title":"Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum Neurotoxin","volume":"25","author":"Garcia-Rodriguez","year":"2007","journal-title":"Nature Biotechnol"},{"key":"10.1016\/j.toxicon.2009.02.034_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/exnr.1997.6580","article-title":"Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies \u2013 therapeutic consequences","volume":"147","author":"G\u00f6schel","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.2003.01598.x","article-title":"Review article: botulinum toxin in the therapy of gastrointestinal motility disorders","volume":"18","author":"Gui","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.toxicon.2009.02.034_bib38","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1212\/01.wnl.0000249308.66959.43","article-title":"Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia","volume":"67","author":"Jankovic","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2009.02.034_bib39","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1474-4422(06)70574-9","article-title":"Treatment of dystonia","volume":"5","author":"Jankovic","year":"2006","journal-title":"Lancet Neurol."},{"issue":"Suppl. 10","key":"10.1016\/j.toxicon.2009.02.034_bib40","first-page":"S31","article-title":"Botulinum toxin type B observational study (BOS)","volume":"20","author":"Jankovic","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2009.02.034_bib41","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/01.WNL.0000055087.96356.BB","article-title":"Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia","volume":"60","author":"Jankovic","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2009.02.034_bib42","series-title":"Scientific and Therapeutic Aspects of Botulinum Toxin","first-page":"409","article-title":"Botulinum toxin: clinical implications of antigenicity and immunoresistance","author":"Jankovic","year":"2002"},{"key":"10.1016\/j.toxicon.2009.02.034_bib43","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"Suppl. 8","key":"10.1016\/j.toxicon.2009.02.034_bib44","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1002\/mds.20024","article-title":"Treatment of cervical dystonia with botulinum toxin","volume":"19","author":"Jankovic","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2009.02.034_bib45","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nature05387","article-title":"Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity","volume":"444","author":"Jin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2009.02.034_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/bj1910261","article-title":"A novel and comprehensive synthetic approach for the elucidation of protein antigenic structures. Determination of the full antigenic profile of the alpha-chain of human haemoglobin","volume":"191","author":"Kazim","year":"1980","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2009.02.034_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/bj2030201","article-title":"Structurally inherent antigenic sites. Localization of the antigenic sites of the alpha-chain of human haemoglobin in three host species by a comprehensive synthetic approach","volume":"203","author":"Kazim","year":"1982","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2009.02.034_bib48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/bj1670275","article-title":"Prediction and confirmation by synthesis of two antigenic sites in human haemoglobin by extrapolation from the known antigenic structure of sperm whale myoglobin","volume":"167","author":"Kazim","year":"1977","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2009.02.034_bib49","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/IAI.18.3.761-766.1977","article-title":"Development of anti-toxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin","volume":"18","author":"Kozaki","year":"1977","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2009.02.034_bib50","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1128\/IAI.57.9.2634-2639.1989","article-title":"Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes","volume":"57","author":"Kozaki","year":"1989","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2009.02.034_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7883\/yoken1952.34.61","article-title":"Separation of Clostridium botulinum type A derivative toxin into two fragments","volume":"34","author":"Kozaki","year":"1981","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01891992","article-title":"Covalent structure of botulinum neurotoxin type A: location of sulfhydryl groups, and disulfide bridges and identification of C-termini of light and heavy chains","volume":"13","author":"Krieglstein","year":"1994","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.toxicon.2009.02.034_bib53","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type A and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1020655701852","article-title":"In vitro translation of type A Clostridium botulinum neurotoxin heavy chain and analysis of its binding to rat synaptosomes","volume":"18","author":"Li","year":"1999","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.toxicon.2009.02.034_bib55","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.febslet.2006.02.074","article-title":"The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves","volume":"580","author":"Mahrhold","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2009.02.034_bib56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneumeth.2005.05.026","article-title":"Inhibition by human sera of botulinum neurotoxin-A binding to synaptosomes: a new assay for blocking and non-blocking antibodies","volume":"151","author":"Maruta","year":"2006","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.toxicon.2009.02.034_bib57","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10930-004-7881-3","article-title":"Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chain","volume":"23","author":"Maruta","year":"2004","journal-title":"Protein J."},{"key":"10.1016\/j.toxicon.2009.02.034_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4615-1891-4_11","article-title":"Protection strategies against botulinum toxin","volume":"383","author":"Middlebrook","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1017\/S0033583500003292","article-title":"Structure and function of tetanus and botulinum neurotoxins","volume":"28","author":"Montecucco","year":"1995","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.toxicon.2009.02.034_bib60","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1016\/S0021-9258(17)34087-5","article-title":"Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes","volume":"269","author":"Nishiki","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2009.02.034_bib61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0014-5793(95)01471-3","article-title":"The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b\/GD1a","volume":"378","author":"Nishiki","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2009.02.034_bib62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3940(96)12557-X","article-title":"Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA","volume":"208","author":"Nishiki","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.toxicon.2009.02.034_bib63","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4049\/jimmunol.121.3.866","article-title":"Genetic control of immune response to sperm whale myoglobin in mice. I. T lymphocyte proliferative response under H-2-linked Ir gene control","volume":"121","author":"Okuda","year":"1978","journal-title":"J. Immunol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib64","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4049\/jimmunol.123.1.182","article-title":"Genetic control of immune response to sperm whale myoglobin in mice. II. T lymphocyte proliferative response to the synthetic antigenic sites","volume":"123","author":"Okuda","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib65","doi-asserted-by":"crossref","first-page":"23479","DOI":"10.1016\/S0021-9258(18)35863-0","article-title":"Botulinum neurotoxins are zinc proteins","volume":"267","author":"Schiavo","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2009.02.034_bib66","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1517\/14656566.2.10.1649","article-title":"Review of botulinum toxin type A and its clinical applications in migraine headache","volume":"10","author":"Silberstein","year":"2001","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.toxicon.2009.02.034_bib67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.pa.26.040186.002235","article-title":"Molecular pharmacology of botulinum toxin and tetanous toxin","volume":"26","author":"Simpson","year":"1986","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib68","series-title":"Botulinum Neurotoxin and Tetanus Toxin","first-page":"153","article-title":"Peripheral actions of the botulinum toxins","author":"Simpson","year":"1989"},{"key":"10.1016\/j.toxicon.2009.02.034_bib69","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/78005","article-title":"Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B","volume":"7","author":"Swaminathan","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib70","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","article-title":"Botulinum and tetanus neurotoxins: structure, function and therapeutic utility","volume":"27","author":"Turton","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.toxicon.2009.02.034_bib80","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0161-5890(81)90107-3","article-title":"Genetic control of the immune response to myoglobin. IV. Mouse Antibodies in outbred and congenic strains against sperm whale myoglobin recognize the same antigenic sites that are recognized by antibodies raised in other species","volume":"18","author":"Twining","year":"1981","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.toxicon.2009.02.034_bib71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nn783","article-title":"Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis","volume":"5","author":"Washbourne","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.toxicon.2009.02.034_bib72","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1046\/j.1471-4159.1999.0732424.x","article-title":"Botulinum neurotoxin E-insensitive mutants of SNAP-25 fail to bind VAMP but support exocytosis","volume":"73","author":"Washbourne","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxicon.2009.02.034_bib73","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1432-1033.1983.tb07282.x","article-title":"Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes","volume":"131","author":"Williams","year":"1983","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxicon.2009.02.034_bib74","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.71.5.2941-2944.2003","article-title":"Expression of HC subunits from Clostridium botulinum types C and D and their evaluation as candidate vaccine antigens in mice","volume":"71","author":"Woodward","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2009.02.034_bib75","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1042\/bj2340441","article-title":"Antigenic structure of human haemoglobin: localization of the antigenic sites of the \u03b2-chain in three host species by synthetic overlapping peptides representing the entire chain","volume":"234","author":"Yoshioka","year":"1986","journal-title":"Biochem. J."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010109001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010109001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T12:07:45Z","timestamp":1684930065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010109001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0041010109001275"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2009.02.034","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}